Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × efineptakin alfa × Dermatologic × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Interventional 1 Expanded_access 1

Sponsor

Cancer Type

Dermatologic 1 CNS 1

Conditions

Melanoma 1 Glioma 1 Glioblastoma 1

Interventions

trametinib 3 dabrafenib 3 talimogene laherparepvec 2 pembrolizumab 2 Nivolumab 2 Ipilimumab 2 ulixertinib 1 tebentafusp 1 pegilodecakin 1 omaveloxolone 1 methyl 5-aminolevulinate 1 efineptakin alfa 1 cemiplimab 1 balstilimab 1 avelumab 1 aldesleukin 1 Rose Bengal 1 Melphalan 1 HhAntag691 1 Cyclophosphamide 1 Brentuximab Vedotin 1 AM0010 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04289155 2022-03-17

Individual Patient Compassionate Use of GX-I7

Genexine, Inc.

No longer available

CNSDermatologic

Glioblastoma, Glioma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡